Postes actifs de Steven J. Harper
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Exonate Ltd.
 Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Directeur/Membre du Conseil | 05/12/2013 | - |
| Fondateur | 05/12/2013 | - | |
| Corporate Officer/Principal | 05/12/2013 | - |
Historique de carrière de Steven J. Harper
Statistiques
Internationale
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Exonate Ltd.
Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Health Services |
- Bourse
- Insiders
- Steven J. Harper
- Expérience
